Peptide record

TPDB64750

D-T7 Blood-Brain Barrier modified_plain modified
8 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB64750
D-T7
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
B3Pred BBPpredict Peptipedia
modified_plain
Yes
A 8-aa modified blood-brain barrier peptide sequence curated from B3Pred, BBPpredict, and Peptipedia, with an available 3D structural model.
C-terminal: Cysteine on C-terminal
Sequence
HRPYIAHC
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
8 reviewed residue count
Cysteine on C-terminal Activity
Linear Activity
HisArgProTyrIleAlaHisCys Activity
N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CS)C(=O)O Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
3.31-fold higher than saline

Target

bEnd.3 and c6 cells

Assay & Model

Confocal microscopy
It crosses the BBB.
PTX-1.7 mg/kg, CD-3.6 mg/kg
Glioma
Stability/half life

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
D-T7 Peptide Modified PEGylated Bilirubin Nanoparticles Loaded with Cediranib and Paclitaxel for Ant
Combined with Cediranib and Paclitaxel.
Additional Detail Fields 1 fields
Intravenous